Anthracyclines have been a mainstay of breast cancer therapy for decades, with strong evidence demonstrating their impact on breast cancer survival. Apart from the proven efficacy, associated toxicity has raised concern on the use of anthracyclines and turned the spotlight on anthracycline-free regimens.
This presentation will review the role of anthracyclines in treatment of early breast cancer and share insights on anthracycline-free regimen based on clinical evidence.

時間:2023年11月15日(三)18:50-21:00 ，地點:乳e學院線上直播